IGHS had the pleasure to welcome SanderStrothmann in Coimbra

The IGHS Group, through its subsidiary INNOV-CELL THERAPEUTICS, has been focused on the development of innovative biotechnological-based therapeutic solutions in the dermatological sector. 
This week we had the pleasure to welcome in Coimbra some elements of the german multinational company SanderStrothmann GmbH, with the main goal to strengthen our commercial relationship.

Two days of intense work where were discussed new projects that resulted in the guarantee of the development of new innovative products to reinforce the Kelo.Cell product line. 
Our guests had also the opportunity to visit BASI Laboratories, located in Mortágua.

Combining innovation and high quality, next year IGHS will have new products, developed by SanderStrothmann’s R&D, available on the market. 
Another investment of IGHS Group focused on the overall health of the patient.

• A FUTURE MADE OF SYNERGIES: the hospital where academia and industry come together for a better and healthier world

  The Oman International Hospital (OIH) and the Coimbra Higher School of Health Technology (ESTeSC) signed a protocol yesterday, with a view to carrying out internships for ESTeSC members at OIH facilities, in Oman.

  Read more
• LIFELONG LEARNING– a pathway towards clinical excellence at oman international hospital

  The Oman International Hospital (OIH) started this February 1, the MED ACADEMY, a 10-years project powered by Siemens Healthineers.
  The overall goal of Med Academy is promoting technical and clinical know-how of OIH employees aiming to increase skills leading to the provision of the best health care, in line with the highest quality standards worldwide.
   

  Read more